Literature DB >> 5153652

Survival in scleroderma.

R Bennett, R Bluestone, P J Holt, E G Bywaters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5153652      PMCID： PMC1005833          DOI： 10.1136/ard.30.6.581

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

2.  Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.

Authors:  R G FARMER; R W GIFFORD; E A HINES
Journal:  Circulation       Date:  1960-06       Impact factor: 29.690

3.  Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.

Authors:  M MERRELL; L E SHULMAN
Journal:  J Chronic Dis       Date:  1955-01

4.  Statistics; servant of all sciences.

Authors:  J NEYMAN
Journal:  Science       Date:  1955-09-02       Impact factor: 47.728

5.  Scleroderma (diffuse systemic sclerosis).

Authors:  E R CULLINAN
Journal:  Proc R Soc Med       Date:  1953-07

6.  Acrosclerosis.

Authors:  S C TRUELOVE; H M WHYTE
Journal:  Br Med J       Date:  1951-10-13

7.  Systemic sclerosis and small bowel involvement.

Authors:  R Bluestone; M Macmahon; J M Dawson
Journal:  Gut       Date:  1969-03       Impact factor: 23.059

8.  Lung function and the response to exercise in systemic sclerosis.

Authors:  S Godfrey; R Bluestone; B E Higgs
Journal:  Thorax       Date:  1969-07       Impact factor: 9.139

9.  Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore.

Authors:  A T Masi; W A D'Angelo
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391
  9 in total
  24 in total

1.  Systemic sclerosis in the elderly.

Authors:  L Czirják; Z Nagy; G Szegedi
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

2.  Predictors of survival in 171 patients with systemic sclerosis (scleroderma).

Authors:  Z Nagy; L Czirják
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

3.  Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon.

Authors:  Madeleine Meli; Gabriela Gitzelmann; Renate Koppensteiner; Beatrice R Amann-Vesti
Journal:  Clin Rheumatol       Date:  2005-06-11       Impact factor: 2.980

4.  Renal involvement in progressive systemic sclerosis.

Authors:  M I Jayson
Journal:  Proc R Soc Med       Date:  1975-09

Review 5.  Raynaud's phenomenon: its relevance to scleroderma.

Authors:  J J Belch
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

6.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

Review 7.  Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.

Authors:  C G Kallenberg
Journal:  Clin Rev Allergy       Date:  1994

8.  Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?

Authors:  P M Houtman; C G Kallenberg; A A Wouda; T H The
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

9.  Survival in progressive systemic sclerosis with pulmonary involvement: a single-center experience in Istanbul, Turkey.

Authors:  Ferit Zuhur; Sayid Shafi Zuhur; Cigdem Zuhur; Benan Musellim; Gul Ongen
Journal:  Rheumatol Int       Date:  2011-03-05       Impact factor: 2.631

Review 10.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.